Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

Asher A. Chanan-Khan, Sagar Lonial, Donna Weber, Ivan Borrello, Robin Foà, Andrzej Hellmann, Meletios Dimopoulos, Arlene S. Swern, Robert Knight

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences